Mackay Clinical School
Leanne Hall
- Senior Research Officer
- leanne.hall@jcu.edu.au
Kristiana Reitano
- Academic Advisor
- kristiana.pederick@jcu.edu.au
Veronica Stanganelli
- Senior Lecturer - Psychiatry
- veronica.stanganelli@jcu.edu.au
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
Leanne Hall
01 Jun 2024 - 31 May 2026
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Electronic medical record quaity impact (eMEDI-QI) Study (Old ID 27069)
Leanne Hall
17 Dec 2020 - 28 Feb 2022
This study involves application of a daa extraction tool to detect patients at risk for familial hypercholesterolaemia (FH). People with FH are at inceased risk of premature death from coronary artery diseases. The dominent genetic natgure means at least one parent of the patient will have FH, and 50% and 25% chance of their siblings and children having FH respectively. It's estimated only 10% of patients are currently identified. The aim is to identify patients with FH and target the 50% of first-degree relatives in families with FH. Identifying patients with FH benefits with patient, siblings, parents and future generations.
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
Leanne Hall
04 Dec 2024 - 19 Feb 2029
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced
euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of
diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the
aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
Leanne Hall
04 Dec 2024 - 19 Feb 2029
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced
euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of
diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the
aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Cohort profile: why do people keep hurting their back?
- 2020
- Biomed Central
- Researchers:Leanne Hall
Impact of new diagnostic pathway for gestational diabetes in time of COVID-19
- 2023
- Sage Publications
- Researchers:Leanne HallClare Heal
The effect of COVID-19 on medical student clinical skill practice and self-perceived proficiency
- 2023
- Association for Medical Education in Europe
- Researchers:Leanne HallClare Heal
Start Date:
01 Jan 2010
Start Date:
01 Jan 2020
Start Date:
01 Jan 2018
Start Date:
01 Jan 2024